Gamma Knife Market, by Indication (Brain Metastasis, Arteriovenous Malformation (AVM), Trigeminal Neuralgia, and Others), by Anatomy (Head, Neck, and Others), by End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Region (North America,

Gamma Knife Market, by Indication (Brain Metastasis, Arteriovenous Malformation (AVM), Trigeminal Neuralgia, and Others), by Anatomy (Head, Neck, and Others), by End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Gamma knife radiosurgery is a radiation type of therapy used to treat tumors, vascular malformations, and other abnormalities in the brain. Gamma knife radiosurgery is different from other forms of stereotactic radiosurgery (SRS), as in gamma knife surgery there is no incision. Moreover, gamma knife radiosurgery uses specialized equipment to focus about 200 tiny beams of radiation on a tumor or other target with submillimeter accuracy. A strong dose of radiation is delivered to the place where all the beams meet, as compared to effect of each beam. The precision of brain stereotactic radiosurgery results in minimal radiation delivery to healthy tissues surrounding the target. This type of radiation treatment is usually performed, if a person is suffering from a tumor or other abnormality in the brain that is difficult to reach with standard neurosurgery, or a person is not healthy enough to undergo standard surgery, and if a person prefers a less invasive treatment.
Market Dynamics
Increasing collaboration between major players is expected to drive the global gamma knife market. For instance, in March 2020, Elekta and San Jose Moscati Hospital teamed up to equip new center in Queretaro State with comprehensive range of radiotherapy solutions, to treat cancer patients in Mexico. The agreement comprises a broad array of cancer treatment and radiotherapy support systems such as Elekta Unity, Leksell Gamma Knife, and brachytherapy using Flexitron, Versa HD linear accelerator, and MOSAIQ oncology information system.
However, growth of the global gamma knife market is expected to be hampered over the forecast period, owing to increasing FDA recalls. For instance, in May 2017, the U.S. Food and Drug Administration recalled the Leksell Gamma Knife Icon developed by Elekta, Inc., under Class 2 Device Recall due to safety issues.
Key features of the study:
This report provides in-depth analysis of the global gamma knife market size (US$), and compound annual growth rate (CAGR) for the forecast period (2022 - 2028), considering 2021 as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players.
It profiles key players in the global gamma knife market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Elekta AB, American Radiosurgery inc., and Masep Medical Science & Technology Development Co., Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global gamma knife market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for dialysis market, research and consulting firms, new entrants, and financial analysts.
Detailed Segmentation:
Global Gamma Knife Market, By Indication:
Brain Metastasis
Arteriovenous Malformation (AVM)
Trigeminal Neuralgia
Others
Global Gamma Knife Market, By Anatomy:
Head
Neck
Others
Global Gamma Knife Market, By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Global Gamma Knife Market, By Region:
North America
By Country:
U.S.
Canada
By Indication
Brain Metastasis
Arteriovenous Malformation (AVM)
Trigeminal Neuralgia
Others
By Anatomy
Head
Neck
Others
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Indication
Brain Metastasis
Arteriovenous Malformation (AVM)
Trigeminal Neuralgia
Others
By Anatomy
Head
Neck
Others
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Indication
Brain Metastasis
Arteriovenous Malformation (AVM)
Trigeminal Neuralgia
Others
By Anatomy
Head
Neck
Others
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Indication
Brain Metastasis
Arteriovenous Malformation (AVM)
Trigeminal Neuralgia
Others
By Anatomy
Head
Neck
Others
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Indication
Brain Metastasis
Arteriovenous Malformation (AVM)
Trigeminal Neuralgia
Others
By Anatomy
Head
Neck
Others
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Indication
Brain Metastasis
Arteriovenous Malformation (AVM)
Trigeminal Neuralgia
Others
By Anatomy
Head
Neck
Others
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
Company Profiles
Elekta AB*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
American Radiosurgery Inc.
Masep Medical Science & Technology Development Co., Ltd.
“*” marked represents similar segmentation in other categories in the respective section.